Hookipa Pharma Stock Analysis

Hookipa Stock Analysis Notes

About 21.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.33. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hookipa Pharma recorded a loss per share of 3.69. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 10th of July 2024. HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company was incorporated in 2011 and is headquartered in New York, New York. Hookipa Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 131 people. To learn more about Hookipa Pharma call Joern Aldag at 431 890 6360 or check out https://www.hookipapharma.com.

Hookipa Pharma Investment Alerts

Hookipa Pharma Upcoming and Recent Events

Hookipa Largest EPS Surprises

View All Earnings Estimates

Hookipa Stock Institutional Investors

Note, although Hookipa Pharma's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Hookipa Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.39 M.

Hookipa Profitablity

The company has Profit Margin (PM) of (0.93) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (17.37) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $17.37.

Management Efficiency

Hookipa Pharma has return on total asset (ROA) of (0.201) % which means that it has lost $0.201 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4899) %, meaning that it created substantial loss on money invested by shareholders. Hookipa Pharma's management efficiency ratios could be used to measure how well Hookipa Pharma manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.61. The value of Return On Capital Employed is expected to slide to -0.99. At this time, Hookipa Pharma's Non Current Liabilities Other is quite stable compared to the past year. Change To Liabilities is expected to rise to about 4.5 M this year, although the value of Total Current Liabilities will most likely fall to about 25.1 M.

Technical Drivers

As of the 18th of January 2025, Hookipa Pharma retains the Standard Deviation of 5.02, risk adjusted performance of (0.13), and Market Risk Adjusted Performance of 1.07. Hookipa Pharma technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Hookipa Pharma Price Movement Analysis

Hookipa Pharma Insider Trading Activities

Hookipa Pharma Outstanding Bonds

Hookipa Pharma Predictive Daily Indicators

Hookipa Pharma Forecast Models

Hookipa Pharma's time-series forecasting models are one of many Hookipa Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Hookipa Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Hookipa Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hookipa shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Hookipa Pharma. By using and applying Hookipa Stock analysis, traders can create a robust methodology for identifying Hookipa entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Hookipa analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Hookipa analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Hookipa Pharma stock analysis indicators help investors evaluate how Hookipa Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Hookipa Pharma shares will generate the highest return on investment. By understating and applying Hookipa Pharma stock analysis, traders can identify Hookipa Pharma position entry and exit signals to maximize returns.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hookipa Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.